125 related articles for article (PubMed ID: 37689083)
1. HIV pre-exposure prophylaxis as an entry point to the elimination of hepatitis B virus.
Khwairakpam G; Hicks J; Pénicaud C
Lancet Gastroenterol Hepatol; 2023 Nov; 8(11):967. PubMed ID: 37689083
[No Abstract] [Full Text] [Related]
2. Low prevalence of hepatitis B virus infection in HIV-uninfected pregnant women in Cape Town, South Africa: implications for oral pre-exposure prophylaxis roll out.
Joseph Davey D; Hsiao NY; Wendy Spearman C; Sonderup M; Hu NC; Mashele N; Mvududu R; Myer L
BMC Infect Dis; 2022 Sep; 22(1):719. PubMed ID: 36050648
[TBL] [Abstract][Full Text] [Related]
3. Post exposure prophylaxis coverage, vertical transmission and associated factors among hepatitis B exposed newborns delivered at Arsi zone health institutions, 2019.
Bayu H; Elias B; Abdisa S; Tune A; Namo H
PLoS One; 2020; 15(10):e0238987. PubMed ID: 33052919
[TBL] [Abstract][Full Text] [Related]
4. Management of health care workers following occupational exposure to hepatitis B, hepatitis C, and human immunodeficiency virus.
Sin WW; Lin AW; Chan KC; Wong KH
Hong Kong Med J; 2016 Oct; 22(5):472-7. PubMed ID: 27562987
[TBL] [Abstract][Full Text] [Related]
5. A community-based healthcare package combining testing and prevention tools, including pre-exposure prophylaxis (PrEP), immediate HIV treatment, management of hepatitis B virus, and sexual and reproductive health (SRH), targeting female sex workers (FSWs) in Côte d'Ivoire: the ANRS 12381 PRINCESSE project.
Becquet V; Nouaman M; Plazy M; Agoua A; Zébago C; Dao H; Montoyo A; Jary A; Coffie PA; Eholié S; Larmarange J;
BMC Public Health; 2021 Dec; 21(1):2214. PubMed ID: 34863122
[TBL] [Abstract][Full Text] [Related]
6. Trends in Recommended Screening and Monitoring Tests for Users of HIV Pre-Exposure Prophylaxis Before and During the COVID-19 Pandemic.
Unigwe IF; Cook RL; Janelle JW; Park H
AJPM Focus; 2023 Dec; 2(4):100134. PubMed ID: 37790950
[TBL] [Abstract][Full Text] [Related]
7. Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis.
U.S. Public Health Service
MMWR Recomm Rep; 2001 Jun; 50(RR-11):1-52. PubMed ID: 11442229
[TBL] [Abstract][Full Text] [Related]
8. High incidence of HCV in HIV-negative men who have sex with men using pre-exposure prophylaxis.
Hoornenborg E; Coyer L; Boyd A; Achterbergh RCA; Schim van der Loeff MF; Bruisten S; de Vries HJC; Koopsen J; van de Laar TJW; Prins M;
J Hepatol; 2020 May; 72(5):855-864. PubMed ID: 31862485
[TBL] [Abstract][Full Text] [Related]
9. Prophylaxis and follow-up after possible exposure to HIV, hepatitis B virus, and hepatitis C virus outside hospital: evaluation of policy 2000-3.
Sonder GJ; Regez RM; Brinkman K; Prins JM; Mulder JW; Spaargaren J; Coutinho RA; van den Hoek A
BMJ; 2005 Apr; 330(7495):825-9. PubMed ID: 15817550
[TBL] [Abstract][Full Text] [Related]
10. Low Prior Exposure and Incidence of Hepatitis C in Human Immunodeficiency Virus-Negative Gay and Bisexual Men Taking Preexposure Prophylaxis (PrEP): Findings From the Expanded PrEP Implementation in Communities-New South Wales Prospective Implementation Study.
Amin J; Vaccher S; Templeton DJ; Bavinton B; Jin F; Zablotska I; Matthews G; Ogilvie E; Yeung B; Ooi C; Dharan N; Baker DA; Read P; Guy R; Grulich AE
Clin Infect Dis; 2022 Oct; 75(9):1497-1502. PubMed ID: 35352102
[TBL] [Abstract][Full Text] [Related]
11. Risks and benefits of oral HIV pre-exposure prophylaxis for people with chronic hepatitis B.
Mohareb AM; Larmarange J; Kim AY; Coffie PA; Kouamé MG; Boyd A; Freedberg KA; Hyle EP
Lancet HIV; 2022 Aug; 9(8):e585-e594. PubMed ID: 35817068
[TBL] [Abstract][Full Text] [Related]
12. Incidence of Hepatitis C Virus Infections Among Users of Human Immunodeficiency Virus Pre-exposure Prophylaxis.
Tabatabavakili S; Aleyadeh W; Cerrocchi O; Janssen HLA; Hansen BE; Bogoch II; Feld JJ;
Clin Gastroenterol Hepatol; 2022 Mar; 20(3):674-681. PubMed ID: 33737225
[TBL] [Abstract][Full Text] [Related]
13. Antiretroviral agents in pre-exposure prophylaxis: emerging and advanced trends in HIV prevention.
Yap PK; Loo Xin GL; Tan YY; Chellian J; Gupta G; Liew YK; Collet T; Dua K; Chellappan DK
J Pharm Pharmacol; 2019 Sep; 71(9):1339-1352. PubMed ID: 31144296
[TBL] [Abstract][Full Text] [Related]
14. Frequency of Hepatitis B Virus Resistance Mutations in Women Using Tenofovir Gel as Pre-Exposure Prophylaxis.
Baxter C; Ngcapu S; Blackard JT; Powell EA; Penton PK; Abdool Karim SS
Viruses; 2019 Jun; 11(6):. PubMed ID: 31248149
[TBL] [Abstract][Full Text] [Related]
15. Postexposure prophylaxis for deadly bloodborne viral infections.
Edlich RF; Gubler K; Wallis AG; Clark JJ; Dahlstrom JJ; Long WB
J Environ Pathol Toxicol Oncol; 2010; 29(4):293-315. PubMed ID: 21284594
[TBL] [Abstract][Full Text] [Related]
16. Emergency prophylaxis following needle-stick injuries and sexual exposures: results from a survey comparing New York Emergency Department practitioners with their national colleagues.
Merchant RC; Keshavarz R
Mt Sinai J Med; 2003 Oct; 70(5):338-43. PubMed ID: 14631520
[TBL] [Abstract][Full Text] [Related]
17. Qualitative inquiry into perceptions of HIV pre-exposure prophylaxis among people who inject drugs living with hepatitis C in Seattle, WA, USA.
Barry MP; Austin EJ; Bhatraju EP; Glick SN; Stekler JD; Tung EL; Hansen RN; Williams EC; Gojic AJ; Pickering EI; Tsui JI
Harm Reduct J; 2022 Nov; 19(1):121. PubMed ID: 36320005
[TBL] [Abstract][Full Text] [Related]
18. Recommendations for postexposure prophylaxis of operating room personnel and patients exposed to bloodborne diseases.
Edlich RF; Wind TC; Heather CL; Degnan GG; Drake DB
J Long Term Eff Med Implants; 2003; 13(2):103-16. PubMed ID: 14510284
[TBL] [Abstract][Full Text] [Related]
19. A Missed Opportunity for U.S. Perinatal Human Immunodeficiency Virus Elimination: Pre-exposure Prophylaxis During Pregnancy.
Fruhauf T; Coleman JS
Obstet Gynecol; 2017 Oct; 130(4):703-709. PubMed ID: 28885420
[TBL] [Abstract][Full Text] [Related]
20. Pre-Exposure Prophylaxis for viral infections other than HIV.
Soriano V; Treviño A; de Mendoza C; Moreno-Torres V; Pintos I; Barreiro P; Corral O
Infez Med; 2022; 30(3):362-371. PubMed ID: 36148176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
